One clinician. A full patient panel. No operational drag.
Vespyra lets independent clinicians run proactive, high-touch care at scale — by turning spoken decisions into finished work, automatically.
For independent clinicians running direct-pay, longitudinal care — in menopause or beyond.
Proactive care doesn't scale, because the busywork doesn't.
Direct-pay practices have great economics — recurring revenue, no insurance overhead, transparent pricing. But every patient touch still means a clinician manually documenting, messaging, scheduling, and tracking. That cap on capacity is the whole problem.
Lost per patient touch
Documenting, messaging, scheduling, and tracking — repeated across every interaction, every day.
The only two options
To grow, a clinician adds support staff that erodes margin — or stops taking patients. Both stall the model.
Access stays limited
When capacity depends on manual workflows, patients who need proactive care can't get in.
One decision. One workflow. No scattered follow-up.
A patient update comes in. Here's what happens next — without Vespyra, and with it.
The platform proactive care runs on.
Vespyra is the care-delivery platform a clinician runs their proactive practice on. One spoken care decision becomes the finished downstream work — so the clinician makes the call, and Vespyra handles everything after it.
One platform for the whole proactive-care workflow.
A spoken decision becomes the drafted note, the patient plan, the scheduled reassessment, and the tracked follow-up — handled in one place, so nothing scatters across tools and nothing falls through between visits. The clinician makes the call; Vespyra runs the rest of the work.
Watch one sentence become finished work.
Not a description of what Vespyra does — the actual output. One spoken decision, and everything below is written, sent, logged, and scheduled.
A: Inadequate vasomotor control on current estradiol dose. Progesterone tolerated, adequate.
P: ↑ estradiol 0.05 → 0.075 mg/day. Continue progesterone 100 mg nightly. Reassess 4 wks; advise pt to report no improvement or new symptoms sooner.
The clinician decides. Vespyra carries the rest.
Care is asynchronous by design — and not for convenience. For longitudinal, symptom-based conditions, acting on the full picture over time is better medicine than a 15-minute synchronous snapshot. Patients report between visits; the clinician acts on the complete trajectory on their own schedule; Vespyra carries the coordination. It also happens to be what lets one clinician hold a full panel — because clinician time is no longer capped by the appointment slot.
Patients report, structured
Intake forms and symptom trackers turn scattered patient recall into longitudinal data the clinician can act on.
One natural command
"Increase estradiol, continue progesterone, reassess in four weeks." That's the entire input.
Downstream, automatically
Chart, note, patient plan, reminder, tracker, and follow-up — all generated, sent, and tracked between visits.
Not a prototype. A clinic that runs on it today.
Vespyra was built inside The Menopause Clinic — Louisiana's first telehealth clinic dedicated to perimenopause and menopause care — and has run it for a year.
Active members, one clinician
Member retention
Report meaningful improvement
Paid acquisition
Profitable, lean operating model
The need is exploding. The supply isn't.
Menopause care is one of the most underserved markets in medicine — enormous demand, almost no trained supply, and a direct-pay model already proving that patients will pay for care that works. That's the gap Vespyra is built to scale into.
US women enter menopause every year
Certified menopause practitioners in the entire country
Of licensed US doctors are certified in menopause care
Projected market growth by 2030 — to roughly $40B
The direct-pay model is how this gap closes — transparent pricing, no insurance overhead, and the retention and satisfaction that prove patients will pay for proactive care.
But that model is capped by manual work — every patient touch still costs a clinician 15–30 minutes. Vespyra is the infrastructure that lifts the cap, so one clinician can meet far more of the demand without building a team to do it.
Sources: The Menopause Society; Boston Consulting Group, Closing the Menopause Care Gap, 2025.
Built for menopause. Generalizes to protocol-driven chronic care.
Vespyra was proven in menopause because that care is longitudinal, symptom-based, education-heavy, and protocol-driven. The same infrastructure fits any condition with that shape — each new one adds clinical content to the platform, not a new build.
Thyroid, diabetes, metabolic care
Protocol-driven, lab-tracked, and adjusted continuously between visits.
PCOS, endometriosis, fertility
Clinically adjacent to menopause — the natural next verticals.
Hypertension, autoimmune, GI*
Any chronic condition managed proactively over time, not in episodic visits.
* Some conditions benefit from additional remote monitoring. Vespyra is designed to work alongside those tools for comprehensive longitudinal care.
Built by the clinician who needed it.
Crystal Burke, FNP-C, MSCP
Founder and Clinical Director of The Menopause Clinic. Built the production platform end-to-end while running the clinic on it daily — because nothing else could support proactive longitudinal care.
Steven Youngblood, MD
Clinical advisor. Advises on condition modules, medical content, and literature alignment as Vespyra expands across women's chronic conditions.

